Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

E

ELVN

Enliven Therapeutics Inc

44.33

Nov 02 • 1:48 PM ET +0.08 (0.18%)

Healthcare Biotechnology USA Mid NASD

Peers: AAPG ERAS TYRA IDYA RLAY KURA SNDX NVS BDTX TAK

| Held by: VTI IWM VXF IWO IBB DFAS VTWO SCHA IHE XPH

Scroll to Statements

Index	RUT
Market Cap	3.25B
Enterprise Value	2.35B
Income	-105.93M
Sales	0.00M
Book/sh	12.22
Cash/sh	12.22
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	60
IPO	Mar 12, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	3.63
P/C	3.63
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	64.07
Current Ratio	64.07
Debt/Eq	0.00
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-1.67
EPS next Y	-2.27
EPS next Q	-0.45
EPS this Y	-1.48%
EPS next Y	-22.29%
EPS next 5Y	-15.63%
EPS past 3/5Y	46.65% 33.56%
Sales past 3/5Y	- -
EPS Y/Y TTM	16.62%
Sales Y/Y TTM	-
EPS Q/Q	-0.97%
Sales Q/Q	-
Earnings	Aug 05 AMC
EPS/Sales Surpr.	-26.55% -

Insider Own	16.82%
Insider Trans	-10.16%
Inst Own	97.96%
Inst Trans	41.20%
ROA	-14.98%
ROE	-15.31%
ROIC	-11.82%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	6.76%
SMA50	-8.39%
SMA200	3.51%
Trades

Shs Outstand	73.25M
Shs Float	60.95M
Short Float	15.31%
Short Ratio	6.92
Short Interest	9.33M
52W High	62.32 -28.87%
52W Low	14.78 199.83%
Volatility	4.09% 4.42%
ATR (14)	1.87
RSI (14)	51.35
Beta	0.34
Rel Volume	0.39
Avg Volume	1.35M
Volume	352,458

Perf Week	6.85%
Perf Month	-5.62%
Perf Quarter	-27.46%
Perf Half Y	6.54%
Perf YTD	187.86%
Perf Year	89.28%
Perf 3Y	263.66%
Perf 5Y	173.64%
Perf 10Y	-
Recom	1.13
Target Price	73.92
Prev Close	44.25
Price	44.33
Change %	0.18%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)